Glioblastoma Treatment Drugs Market : Global Industry Analysis and Opportunity Assessment, 2036

Future Market Insights

Glioblastoma Treatment Drugs Market

Key Insight

Glioblastoma treatment drugs sales will expand through 2036, with antineoplastic at 27.9% of drug type sales and hospitals at 67.2% within the distribution channel segment in 2026. The market was valued at USD 844.8 million in 2025 and is forecast to record a 5.7% CAGR between 2026 and 2036.

July 15, 2026

Anurag Sharma

324 Pages

Cite this Report

Glioblastoma Treatment Drugs Market

https://www.futuremarketinsights.com/reports/glioblastoma-treatment-drugs-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Bayer
Celgene Corporation
Novartis
The Vanguard Group
Roche

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Glioblastoma Treatment Drugs Market

Key Players

Similar Industry Reports